Intuitive Surgical, US46120E6023

Intuitive Surgical stock: BofA raises price target to $500

Published on 11/17/2026 at 17:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Intuitive Surgical stock keeps BofA's Buy rating as the bank lifts its target. The move sharpens the analyst debate after the latest results.

BofA shifts its valuation view

  • BofA retained its Buy rating while raising its price objective for Intuitive Surgical.
  • The analyst action followed the company's third-quarter results and broader debate over medical-technology demand.
Intuitive Surgical, US46120E6023, Illustration mit AI erstellt.

On November 10, BofA Securities analyst Travis Steed reaffirmed a Buy rating on Intuitive Surgical and raised the price target from 470 US dollars to 500 US dollars, according to Poisar. The change gives investors a higher sell-side valuation marker while leaving the bank's positive rating unchanged.

What changed in BofA's view

BofA's note points to a less negative mood across medical technology after Intuitive Surgical's third-quarter results and the US election. The bank also sees a possible pause for the group while investors assess whether lower 2027 consensus estimates can be exceeded, according to the cited report.

For Intuitive Surgical, the analyst action keeps attention on procedure growth, system placements and the outlook for the surgical robotics market. It is an external valuation view rather than a change to company guidance, so investors must weigh the higher target against the operating risks already reflected in the post-results debate.

Investor context

The company recently announced that Aaron Martin, Humana's President of Insurance, will join its board on January 1, 2027. That governance change is separate from BofA's valuation action and expands the board's healthcare, payer and digital-health experience.

Intuitive Surgical at a glance

  • Company: Intuitive Surgical, Inc.
  • ISIN: US46120E6023
  • Ticker: ISRG
  • Analyst action: BofA Securities retained Buy and raised its price target from 470 US dollars to 500 US dollars
  • Event date: November 10, 2026

Broader market context is available in Current market reports.

More news and analyses on Intuitive Surgical stock

Disclaimer...
en | US46120E6023 | INTUITIVE SURGICAL | boerse | 70527762 | bgmi